Associate Scientist 4
Alexion
Associate Scientist 4
Alexion
Global biopharmaceuticals focusing on rare diseases
This is what you will do:
The Associate Scientist IV will join Injectable Drug Product Development group to support the formulation and drug product process development of Alexion’s biotherapeutic candidates. This individual will develop injectable formulations with fit for purpose analytical methods, perform analytical testing, and draft reports for the executed studies. This individual will work independently in a dynamic team environment and routinely collaborate with other members of Injectable Drug Product Development as well as other groups in Product Development and Clinical Supply.
You will be responsible for:
You will need to have:
We would prefer for you to have:
Date Posted
05-Nov-2026Closing Date
18-Nov-2026Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.
Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.
Explore more opportunities at Alexion